Tap Into the $65B 'Shroom Boom'
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
| Open | 7.95 | Prev Close | 8.07 |
| High | 8.07 | Low | 7.79 |
| Volume | 1,884,911 | Volume (Avg) | 1,702 |
| 52 Week High | 9.48 | 52 Week Low | 6.50 |
| Market Cap | 2.5B | PE Ratio |
General
| Name | Amneal Pharmaceuticals Inc |
| Ticker | AMRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 8,300 |
About Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders. This segment provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid and ONGENTYS for the treatment of hypothyroidism; and CREXONT which is use for the treatment of Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, retail pharmacies, managed care organizations, purchasing co-ops, hospitals, government agencies, institutions, and pharmaceutical companies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
Highlights
| Analyst Target | 11.75 |
| Market Cap | 2,451,000,000 |
| EBITDA | 605,020,032 |
Valuation
| Forward PE | 6.30 |
| Price/Sales (Trailing 12 Mt.) | 1.33 |
| Price/Book (Most Recent Quarter) | 86.10 |
Technicals
| Beta | 1.12 |
| 52 Week High | 9.48 |
| 52 Week Low | 6.50 |
| 50 Day Average | -0.81% |
| 200 Day Average | -3.24% |
Earnings
Jim Cramer Recommends This 'Really, Really Good' Energy Stock
Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.
Why Is Donald Trump Ignoring Elon Musk's Call For 'Phase 2' Of The Epstein Files?
Musk's post questioning Trump's unfulfilled promise of Epstein-related disclosures reignites tensions over transparency in politics and tech.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Donald Trump Files $10 Billion Lawsuit Against WSJ And Rupert Murdoch
Donald Trump has filed a $10 billion defamation lawsuit against The Wall Street Journal and Rupert Murdoch.
Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs
On Wednesday, Cathie Wood-led Ark Invest executed significant trades, including substantial purchases in Tempus AI Inc. (NASDAQ:TEM), NVIDIA Corp. (NASDAQ:NVDA), 3iQ Ether Stakin
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Elon Musk Returns To Intense Work Schedule: 'Back To Working 7 Days a Week and Sleeping in the Office'
Elon Musk has announced his return to a grueling work schedule, indicating a shift back to "wartime CEO" mode.
Russia insists on achieving Ukraine goals despite Trump's ultimatum
Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
Elizabeth Warren Has The Receipts: 'Bribery In Plain Sight' Funding Trump's Library
Several companies have donated to President Donald Trump's future presidential library. Senator Elizabeth Warren calls this potential "bribery in plain sight."
Bitcoin's 4-Year Cycle Is Dead, Researcher Says: Here's Why It Matters For XRP
The crypto market has changed, and experts say relying on the traditional 4-year halving cycle could leave investors poorly positioned in
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
AMD Stock Is Sliding Tuesday: What's Driving The Action?
Shares of Advanced Micro Devices are trading lower Tuesday afternoon. The stock is caught in a broader downturn affecting the semiconductor industry.
XRP Falls Nearly 2.5% As Ripple Co-Founder Transfers $150 Million Worth Of Coins From Wallet — Analyst Says, 'He's Dumping On You'
A wallet tied to Ripple co-founder and executive chairman Chris Larsen transferred out hundreds of millions worth of XRP (CRYPTO: XRP) over the last week.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Millions Over Morals: Survey Reveals Americans' Willingness To Sacrifice Love And Loyalty For Cash
A recent poll has uncovered that a significant number of Americans would willingly forsake love, betray friends, and even risk their own lives for a million-dollar windfall.
What's in the Republican bill cutting $9 billion from public broadcasting and foreign aid
WASHINGTON (AP) — The Republican-led Congress is testing the popularity of spending cuts this week by aiming to pass President Donald Trump’s request to in public broadcasting and foreign aid spending.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Verizon Beats Expectations, Boosts Outlook — Here's Why Analysts Still See More Room To Grow
Verizon's Q2 results beat expectations, driven by wireless and broadband offerings. Analysts raised price targets, but net additions were lower.
Lin-Manuel Miranda will turn 'Hamilton' 10th anniversary into a fundraiser for immigration services
plans to use the Broadway performance of his award-winning cultural phenomenon as a fundraiser for a coalition of nonprofits providing immigration services.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Elon Musk Once Revealed How He Comes Up With 'Crazy Ideas' — And Gets Them Off The Ground Even When Funding Is Scarce
Elon Musk once explained that he turns ambitious ideas into reality by starting with low-cost software ventures, using first principles thinking, and combining insights across industries—even without major funding.
Retirees, here’s how to tweak the 4% rule to protect your nest egg
New retirees might enter a different environment than their predecessors—the economy or market might have changed slightly or dramatically.
Don't Touch Tesla Stock Without Reading This First - Ad
Jeff Brown, an early Tesla bull, warns of a strange "Tesla Glitch" uncovered by Wall Street legend Larry Benedict. This anomaly has preceded $25B-$100B swings in Tesla's value - and he's using it to anticipate moves without buying or shorting a single share.
Bitcoin Could Explode to $136,000 if This Happens, Says Analytics Firm
In a recent prediction by analytics platform Glassnode, Bitcoin‘s (CRYPTO: BTC) value could potentially surge by roughly 15%, reaching a staggering $136,000, if current demand continues. However, there is a possible hitch to this prediction.
Nvidia-Supplier Taiwan Semiconductor On A Roll, Profit Explodes With Strong Margin Growth
Taiwan Semiconductor (TSM) reports strong Q2 results and expects continued growth in demand for advanced processor technologies, with revenue guidance of $31.8 billion to $33.0 billion for Q3.
Crypto Genius: These 5 Altcoins Could Crush Bitcoin in 2025 - Ad
On August 30th, two powerful "Wealth Drivers" ignite what could be a 2025 super bull run-backed by Trump. The altcoin market as a whole has already soared 132,721% over the past ten years and could surge again. A $900 stake could turn into $108K over 12 months. This is The Great Gain of 2025.
Circle CEO: Stablecoins Are Going Mainstream — Fast
Jeremy Allaire, CEO of Circle Internet Group, Inc. (NYSE:CRCL), is offering a compelling vision for the future of digital finance and the role of stablecoins in the global economy.
Elon Musk's xAI Plans To Raise $12 Billion In Debt To Buy Nvidia Chips And Build One Of The World's Largest AI Superclusters: Report
Elon Musk's xAI is reportedly seeking $12 billion in debt financing to buy Nvidia chips and build a massive AI supercluster, signaling an aggressive push to stay competitive in the global AI arms race.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Cathie Wood Pounces On Tesla Dip: Ark Snaps Up $43.7 Million In EV Stock While Ditching Crypto Shares Amid Bitcoin Frenzy
On Thursday, Cathie Wood-led Ark Invest made significant trades, prominently featuring the purchase of Tesla Inc. (NASDAQ:TSLA) shares across multiple ETFs.
Jamie Dimon Reveals A Coffee Table Chat With Jeff Bezos In 1999 That Almost Made Him 'Never Wear A Suit Again…Live On A Houseboat'
JPMorgan Chase CEO Jamie Dimon almost left Wall Street for Amazon in 1999 after a chat with Jeff Bezos, but ultimately stayed and became a successful investor.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Trump's Backroom Billionaire: Bezos Meets As SpaceX Fades
President Donald Trump reportedly meets with Jeff Bezos as ties with SpaceX's Elon Musk evaporate.
Want To Bet Bigger On UnitedHealth? Now There's A Cheaper Way
New UNHG ETF offers 200% daily exposure to UnitedHealth Group with low expense ratio. Themes ETFs adds to roster with 20 single-stock leveraged ETFs.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Elizabeth Warren Sounds Alarm on Tariffs: 'The Impact of Six Months of Donald Trump Will Be Felt for Two Generations'
Sen. Elizabeth Warren has voiced concern over the long-term impact of President Trump's tariffs.
From tech podcasts to policy: Trump's new AI plan leans heavily on Silicon Valley industry ideas
An artificial intelligence agenda that started coalescing on the podcasts of is now being forged into U.S. policy as President Donald Trump leans on the ideas of the who backed his election campaign.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
US-EU trade deal wards off further escalation but will raise costs for companies, consumers
FRANKFURT, Germany (AP) — and European Commission President Ursula von der Leyen have that imposes 15% tariffs on most European goods, warding off Trump's threat of a 30% rate if no deal had been reached by Aug. 1.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.